Inventor · disambiguated record
Hiroki Kawauchi
Also filed as: KAWAUCHI HIROKI
7 granted patents·4 pending applications·15 citations·filing 2014–2025
79Inventor score
Files withCHUGAI PHARMACEUTICAL CO LTD11
Top patents by PatentIndex Score
11 records- 0194US11912989B2Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2021·Granted Feb 27, 2024·3 cites·14 claims
- 0289US10961530B2Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2014·Granted Mar 30, 2021·6 cites·21 claims
- 0385US11400157B2Multiple antigen binding molecular fusion, pharmaceutical composition, method for identifying linear epitope, and method for preparing multiple antigen binding molecular fusionCHUGAI PHARMACEUTICAL CO LTD·Filed 2016·Granted Aug 2, 2022·3 cites·12 claims
- 0483US12304960B2Anti-CD137 antigen-binding molecule and utilization thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Granted May 20, 2025·3 cites·27 claims
- 0578US2024158785A1Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said moleculesCHUGAI PHARMACEUTICAL CO LTD·Filed 2024·Application pending·0 cites
- 0677US12415857B2Anti-CTLA-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2023·Granted Sep 16, 2025·0 cites·21 claims
- 0772US12377143B2Multiple antigen binding molecular fusion, pharmaceutical composition, method for identifying linear epitope, and method for preparing multiple antigen binding molecular fusionCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Granted Aug 5, 2025·0 cites·8 claims
- 0871US12448451B2Anti-CTLA-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2022·Granted Oct 21, 2025·0 cites·20 claims
- 0962US2023058982A1Anti-ctla-4 antibody and use thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2019·Application pending·0 cites
- 1062US2025388689A1Anti-cd137 antigen-binding molecule and utilization thereofCHUGAI PHARMACEUTICAL CO LTD·Filed 2025·Application pending·0 cites
- 1150US2022153875A1Antigen-binding molecule containing antigen-binding domain of which binding activity to antigen is changed depending on mta, and library for obtaining said antigen-binding domainCHUGAI PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hiroki Kawauchi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →